Minoxidil (CED0003995)

Record Information
Version1.0
Creation Date2016-05-22 04:28:28 UTC
Update Date2026-05-14 16:36:12 UTC
Accession NumberCHEM017579
Identification
Common NameMinoxidil
ClassSmall Molecule
Description
Minoxidil is an organic compound with the chemical formula C9H15N5O and an average molecular weight of 209.25 g/mol. Minoxidil belongs to the amines, a subclass of organonitrogen compounds within the organic compounds. Industrially, the substance is utilized as a hair fixative as well as a softener and conditioner. The compound is found in healthcare, pharmaceuticals, and veterinary products, specifically within dermatological preparations and antihypertensives. Recorded exposure routes for this compound include oral, cutaneous, topical, and extracorporeal administration. In terms of biological activity, minoxidil interacts with two recorded protein targets: Prostaglandin G/H synthase 1 (PTGS1) and the ATP-sensitive inward rectifier potassium channel 1 (KCNJ1), for which it acts as an inducer.
Contaminant Type
  • Human Neurotoxin
Chemical Structure
Synonyms
ValueSource
AlostilChEBI
Apo-gainChEBI
LonitenChEBI
LonoloxChEBI
MinoxidilumChEBI
MinoximenChEBI
NormoxidilChEBI
RegaineChEBI
RogaineChEBI
TricoxidilChEBI
RiupKegg
Chemical FormulaC9H15N5O
Average Molecular Mass209.248 g/mol
Monoisotopic Mass209.128 g/mol
CAS Registry Number38304-91-5
IUPAC Name2,6-diamino-4-(piperidin-1-yl)pyrimidin-1-ium-1-olate
Traditional Namerogaine
SMILESNC1=CC(=NC(N)=[N+]1[O-])N1CCCCC1
InChI IdentifierInChI=1S/C9H15N5O/c10-7-6-8(12-9(11)14(7)15)13-4-2-1-3-5-13/h6H,1-5,10H2,(H2,11,12)
InChI KeyZFMITUMMTDLWHR-UHFFFAOYSA-N
Chemical Taxonomy
Description Belongs to the class of organic compounds known as dialkylarylamines. These are aliphatic aromatic amines in which the amino group is linked to two aliphatic chains and one aromatic group.
KingdomOrganic compounds
Super ClassOrganic nitrogen compounds
ClassOrganonitrogen compounds
Sub ClassAmines
Direct ParentDialkylarylamines
Alternative Parents
Substituents
  • Dialkylarylamine
  • Aminopyrimidine
  • Imidolactam
  • Pyrimidine
  • Piperidine
  • Heteroaromatic compound
  • Azacycle
  • Organoheterocyclic compound
  • Organic oxygen compound
  • Organopnictogen compound
  • Organic oxide
  • Hydrocarbon derivative
  • Primary amine
  • Aromatic heteromonocyclic compound
Molecular FrameworkAromatic heteromonocyclic compounds
External Descriptors
Biological Properties
StatusDetected and Not Quantified
OriginNot Available
Cellular LocationsNot Available
Biofluid LocationsNot Available
Tissue LocationsNot Available
ApplicationsNot Available
Biological RolesNot Available
Chemical RolesNot Available
Organoleptic EffectsNot Available
Physical Properties
StateNot Available
AppearanceNot Available
Experimental Properties
PropertyValue
Melting PointNot Available
Boiling PointNot Available
SolubilityNot Available
Predicted Properties
PropertyValueSource
Water Solubility19.9 g/LALOGPS
logP1.24ALOGPS
logP1.3ChemAxon
logS-1ALOGPS
pKa (Strongest Acidic)14.22ChemAxon
pKa (Strongest Basic)4.34ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count5ChemAxon
Hydrogen Donor Count2ChemAxon
Polar Surface Area93.63 ŲChemAxon
Rotatable Bond Count1ChemAxon
Refractivity60.74 m³·mol⁻¹ChemAxon
Polarizability21.93 ųChemAxon
Number of Rings2ChemAxon
BioavailabilityYesChemAxon
Rule of FiveYesChemAxon
Ghose FilterYesChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
Spectra
Spectra
Spectrum TypeDescriptionSplash KeyDeposition DateView
GC-MSGC-MS Spectrumsplash10-0002-6953000000-742e0f214f512eecd184Not AvailableView Spectrum
GC-MSGC-MS Spectrumsplash10-00di-9432000000-6fff92eb2f75daf5b772Not AvailableView Spectrum
GC-MSGC-MS Spectrumsplash10-0002-6953000000-742e0f214f512eecd184Not AvailableView Spectrum
GC-MSGC-MS Spectrumsplash10-00di-9432000000-6fff92eb2f75daf5b772Not AvailableView Spectrum
Predicted GC-MSPredicted GC-MS Spectrumsplash10-053u-4910000000-81354ee039c26b1c7d74Not AvailableView Spectrum
Predicted GC-MSPredicted GC-MS SpectrumNot AvailableNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-03di-2960000000-6ce9f8facf6478d7f7eaNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0a4i-0090000000-674539ce0a58d8d1138eNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0a59-9680000000-8c6bee8b5f24585d8926Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0a4l-9610000000-44aa7ff70200e0521eefNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0a4j-9100000000-77920bdc992ad8a2f9bdNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-03dl-9000000000-4d4c7019be9b77462d2eNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-03di-0090000000-86dd850029e96dce7cb4Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-03dl-0950000000-f76a21fbbfffb939b270Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-03di-1900000000-9609dde96093ce0602dcNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-03di-3900000000-f5138ae7a1ba6d04c54aNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-01q9-9800000000-1a8a598ebb2e2427f97fNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0006-0920000000-226902b0b5e18eaca083Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-03di-2960000000-6ce9f8facf6478d7f7eaNot AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-03di-0090000000-b555cbb69de731564653Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-03dj-2890000000-2f17544c7bb461700de3Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-0a4l-9200000000-3ba952a7983d32c46a04Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-0a4j-0890000000-613fa1f07b3b2f1181c6Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-002b-1910000000-9433f9f82c5d6abae125Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-001i-9200000000-96830ec54208ab9a6961Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-0a4i-0090000000-a6c3dcb6c4a5dea3385dNot AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-0a4l-3910000000-699aec6079d9dd23a40aNot AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-052f-9400000000-b7356fe63abaac3ab204Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-03di-0090000000-97a8ab5aa10f1b348768Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-01ox-0940000000-8ab2a87cd70096fc221cNot AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-0lxx-5900000000-cd9c1f56c3ebfeeadbedNot AvailableView Spectrum
1D NMR13C NMR Spectrum (1D, D2O, predicted)Not AvailableNot AvailableView Spectrum
1D NMR1H NMR Spectrum (1D, D2O, predicted)Not AvailableNot AvailableView Spectrum
Toxicity Profile
Mechanism of ToxicityNot Available
Carcinogenicity (IARC Classification)Not Available
Minimum Risk LevelNot Available
SymptomsNot Available
TreatmentNot Available
Toxicity Values
Toxicity ValueUnitValue RangeOrganismDose DescriptorRoute of ExposurePredicted or ExperimentalReference
937.0Log mg/kg[530:1700]RatLD50oralpredictedNot Available
Health Effects
Health EffectRelationshipDirectionReference
Exposure Sources
Source IDSourceSectorReference
289AntihypertensivesHealthcare, pharmaceuticals & veterinary productsNot Available
315Dermatological preparationsHealthcare, pharmaceuticals & veterinary productsNot Available
Pathways
0 pathways

No pathways found

No metabolic pathways have been associated with this synthetic chemical

Targets
StructureProteinUniProt IDOrganismRelationshipDetails
Click to view 3D structureHistamine H4 receptorQ91ZY1Rattus norvegicusPredicted (SEA)5.0602
Click to view 3D structureMyc proto-oncogene proteinP01109Gallus gallusPredicted (SEA)1.47914
Histamine H4 receptor structureClick to view 3D structureHistamine H4 receptorQ9H3N8HumansPredicted (SEA)83.143
Apoptotic protease-activating factor 1 structureClick to view 3D structureApoptotic protease-activating factor 1O14727HumansPredicted (SEA)25.1453
Click to view 3D structureProtein RecAP9WHJ3Mycobacterium tuberculosisPredicted (SEA)211.205
Click to view 3D structureSentrin-specific protease 6Q9GZR1HumansPredicted (SEA)77.7714
Sentrin-specific protease 8 structureClick to view 3D structureSentrin-specific protease 8Q96LD8HumansPredicted (SEA)57.9198
Histamine H3 receptor structureClick to view 3D structureHistamine H3 receptorQ9Y5N1HumansPredicted (SEA)513.727
Click to view 3D structureShort transient receptor potential channel 4Q9QUQ5Mus musculusPredicted (SEA)285.084
Sentrin-specific protease 7 structureClick to view 3D structureSentrin-specific protease 7Q9BQF6HumansPredicted (SEA)348.92
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform structureClick to view 3D structurePhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoformP42336HumansPredicted (SEA)1387.51
Click to view 3D structureHistamine H4 receptorQ91ZY2Mus musculusPredicted (SEA)21.8756
Click to view 3D structureSerine/threonine-protein phosphataseQ9BPW0Homo sapiensPredicted (SEA)4.9045
Serine/threonine-protein kinase mTOR structureClick to view 3D structureSerine/threonine-protein kinase mTORP42345HumansPredicted (SEA)1767.02
Click to view 3D structurePhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoformQ9Z1L0Rattus norvegicusPredicted (SEA)79.4062
Click to view 3D structurePhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoformA0A0G2K344Rattus norvegicusPredicted (SEA)59.4768
Acetylcholinesterase structureClick to view 3D structureAcetylcholinesteraseP22303HumansPredicted (SEA)2682.84
5-hydroxytryptamine receptor 2C structureClick to view 3D structure5-hydroxytryptamine receptor 2CP28335HumansPredicted (SEA)4428.3
Voltage-gated inwardly rectifying potassium channel KCNH2 structureClick to view 3D structureVoltage-gated inwardly rectifying potassium channel KCNH2Q12809HumansPredicted (SEA)6722.05
Click to view 3D structurePhosphodiesteraseF1MPW5Bos taurusPredicted (SEA)58.6205
Urokinase-type plasminogen activator structureClick to view 3D structureUrokinase-type plasminogen activatorP00749HumansPredicted (SEA)1528.18
Adenosine receptor A2a structureClick to view 3D structureAdenosine receptor A2aP29274HumansPredicted (SEA)2919.81
Click to view 3D structureBifunctional dihydrofolate reductase-thymidylate synthaseQ07422Toxoplasma gondiiPredicted (SEA)503.684
Click to view 3D structureHistamine H3 receptorQ9QYN8Rattus norvegicusPredicted (SEA)1061.79
Click to view 3D structurePhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoformP42338HumansPredicted (SEA)3509.29
Concentrations
Not Available
External Links
DrugBank IDDB00350
HMDB IDHMDB0014494
FooDB IDNot Available
Phenol Explorer IDNot Available
KNApSAcK IDNot Available
BiGG IDNot Available
BioCyc IDNot Available
METLIN IDNot Available
PDB IDNot Available
Wikipedia LinkMinoxidil
Chemspider ID10438564
ChEBI ID6942
PubChem Compound IDNot Available
Kegg Compound IDNot Available
YMDB IDNot Available
ECMDB IDNot Available
References
Synthesis ReferenceNot Available
MSDSNot Available
General References
1. Olsen EA, Whiting D, Bergfeld W, Miller J, Hordinsky M, Wanser R, Zhang P, Kohut B: A multicenter, randomized, placebo-controlled, double-blind clinical trial of a novel formulation of 5% minoxidil topical foam versus placebo in the treatment of androgenetic alopecia in men. J Am Acad Dermatol. 2007 Nov;57(5):767-74. Epub 2007 Aug 29.
2. https://www.ncbi.nlm.nih.gov/pubmed/?term=24742982
3. https://www.ncbi.nlm.nih.gov/pubmed/?term=26024233
4. https://www.ncbi.nlm.nih.gov/pubmed/?term=7755612